Mitral stenosis is a cardiac condition characterized by the narrowing of the mitral valve, the valve that separates the left atrium from the left ventricle in the heart. This constriction impedes the smooth flow of blood from the atrium to the ventricle, leading to various cardiovascular complications. Typically associated with rheumatic fever, a historical bacterial infection, mitral stenosis causes symptoms such as shortness of breath, fatigue, and palpitations. As the condition progresses, it can result in decreased cardiac output and increased pressure in the pulmonary veins. Timely diagnosis and intervention, often through medical management or surgical procedures like balloon valvuloplasty or valve replacement, are crucial in managing the impact of mitral stenosis on heart function and improving patients' quality of life.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India